Category: Social
-
Agteria Biotech raises 16 MSEK
(Stockholm, a novel patent-pending molecule with a 70% efficiency in reducing methane from burping and farting cows): Has raised 16 MSEK in a funding round from Norrsken Launcher with members Erik Engellau-Nilsson, Fredrik Jung Abbou and founding member Ash Pournouri alongside Mudcake with member Anna Nordell Westling and founding member Erik Byrenius. “In my seven years at Norrsken, I have not seen a single case that…
-
Dema.ai raises 70 MSEK
(Stockholm, a platform delivering actionable insights for eComm businesses to achieve profitable growth): Has raised 70 MSEK in a funding round from Daphni, J12 and early investors including members Erik Segerborg, Kim Fai Kok and founding member Ash Pournouri. “The e-commerce industry is undergoing fundamental changes, and we want to continue to be at the forefront with the latest technology and lead…
-
Arevo raises 6.6 MUSD
(Umeå, precision nutrition products that enhance plant growth while minimizing nitrogen waste): Has raised 6.6 MUSD in a funding round from Navigare Ventures, Fort Knox, Stora Enso, Kempestiftelserna, and Industrifonden with member Peter Wolpert. “Our initial focus will be on Europe, where there is a critical need for scientifically proven climate innovations that benefit farmers,” comments Niklas Åström.
-
TOP STORIES AROUND THE WORLD
🇳🇴 💰 Norway’s government is criticized for damaging the country’s startup scene through its tax system, especially after the introduction of a new exit tax of over 30%. This tax affects entrepreneurs who leave the country after they have taken in funding, regardless of personal profit from the company. Read more about the new tax here. 🇺🇸 🚀 The forum…
-
Southern Lights raises 18 MSEK
(Stockholm, software solutions to unlock the development of green hydrogen projects): Has raised 18 MSEK in a funding round from Greencode Ventures, Wepa Ventures, and BLING Capital with members Deqa Abukar and Adnan Yousuf. “SaaS solutions for energy are crucial in the fight against climate change, and we are perfectly positioned in terms of timing with the perfect team and expertise to…
-
CemVision raises 110 MSEK
(Stockholm, re-inventing cement by making it environmentally friendly and technically superior): Has raised 110 MSEK in a funding round from Zacua Ventures, Polar Structure with member Tobias Emanuelsson and BackingMinds with founding member Susanne Najafi. “After meeting investors from around the world, we concluded that some of the best is just around the corner, and we are pleased that Polar Structure and BackingMinds are deepening their commitment…
-
Ingrid raises 240 MSEK
(Stockholm, connects retailers, carriers, and consumers to create a better delivery experience for everyone): Has raised 240 MSEK in a funding round from existing investors Schibsted and Verdane with member Henrik Aspén. In Sweden, nearly 20 percent of e-commerce deliveries are already made through Ingrid’s platform today, but now the aim is to conquer Europe. The first stops will be the United…
-
TOP STORIES AROUND THE WORLD
🇪🇺 ✨ There’s a plethora of venture capital firms in Europe – all with different focus areas and geographical homes. Here comes a mapping from Gilion of over 2500 venture capital firms in Europe divided by sectors, focus areas, and geography. 🇸🇪🌟 Researchers at Chalmers in Gothenburg have developed an AI model that detects lymphoma. The model, which is the…
-
Lumeo Tech raises 1.9 MSEK
(Gothenburg, solutions that make wearable devices more versatile, easier to use, and more integrated with our everyday lives): Has raised 1.9 MSEK in a funding round from Nyfikna Investerare with member Joanna Törngren Redebrant. After this latest raise, Lumeo Tech’s total capital from investors amounts to approximately 6.4 MSEK, with a current valuation of around 20.4 MSEK.
-
Asgard Therapeutics raises 30 MEUR
(Lund, direct cell reprogramming technologies to develop ground-breaking cancer immunotherapies): Has raised 30 MEUR in a funding round from Novo Nordisk, JJDC, RV Invest and Industrifonden with member Peter Wolpert. “Asgard’s technology overcomes challenges faced by traditional cell therapies, enabling the recreation of desired functional immune cells directly inside the patient’s body, comments Cristiana Pires, CEO of Asgard Therapeutics.
